United Therapeutics.

> United Therapeutics plans a $500 million manufacturing facility to expand production of its Tyvaso DPI drug-device combination product that received FDA approval last year. The company employs about 460 people in North...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT